BMS-196085 is a potent and selective human β3-adrenergic receptor agonist, exhibiting partial agonist activity (45%) at the β1 receptor. This small molecule is utilized in research to study metabolic disorders, such as obesity and diabetes, in both in vitro and in vivo experimental models.